Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex - Transfer from CD14 to TLR4 and MD-2

被引:505
作者
Correia, JD
Soldau, K
Christen, U
Tobias, PS
Ulevitch, RJ [1 ]
机构
[1] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA
关键词
D O I
10.1074/jbc.M009164200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The structural features of some proteins of the innate immune system involved in mediating responses to microbial pathogens are highly conserved throughout evolution. Examples include members of the Drosophila Toll (dToll) and the mammalian Toll-like receptor (TLR) protein families. Activation of Drosophila Toll is believed to occur via an endogenous peptide rather than through direct binding of microbial products to the Toll protein. In mammals there is a growing consensus that lipopolysaccharide (LPS) initiates its biological activities through a heteromeric receptor complex containing CD14, TLR4, and at least one other protein, MD-2, LPS binds directly to CD14 but whether LPS then binds to TLR4 and/or MD-2 is not known. We have used transient transfection to express human TLRs, MD-2, or CD14 alone or in different combinations in HEK 293 cells, Interactions between LPS and these proteins were studied using a chemically modified, radioiodinated LPS containing a covalently linked, UV light-activated crosslinking group (I-125-ASD-Re595 LPS), Here we show that LPS is cross-linked specifically to TLR4 and MD-2 only when co-expressed with CD14, These data support the contention that LPS is in close proximity to the three known proteins of its membrane receptor complex. Thus, LPS binds directly to each of the members of the tripartite LPS receptor complex.
引用
收藏
页码:21129 / 21135
页数:7
相关论文
共 41 条
[1]   Toll-like receptors in the induction of the innate immune response [J].
Aderem, A ;
Ulevitch, RJ .
NATURE, 2000, 406 (6797) :782-787
[2]   Regulatory roles for CD14 and phosphatidylinositol in the signaling via toll-like receptor 4-MD-2 [J].
Akashi, S ;
Ogata, H ;
Kirikae, F ;
Kirikae, T ;
Kawasaki, K ;
Nishijima, M ;
Shimazu, R ;
Nagai, Y ;
Fukudome, K ;
Kimoto, M ;
Miyake, K .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 268 (01) :172-177
[3]   Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2 [J].
Aliprantis, AO ;
Yang, RB ;
Mark, MR ;
Suggett, S ;
Devaux, B ;
Radolf, JD ;
Klimpel, GR ;
Godowski, P ;
Zychlinsky, A .
SCIENCE, 1999, 285 (5428) :736-739
[4]   Tlr4: central component of the sole mammalian LPS sensor [J].
Beutler, B .
CURRENT OPINION IN IMMUNOLOGY, 2000, 12 (01) :20-26
[5]   MD-2 enables toll-like receptor 2 (TLR2)-mediated responses to lipopolysaccharide and enhances TLR2-mediated responses to gram-positive and gram-negative bacteria and their cell wall components [J].
Dziarski, R ;
Wang, QL ;
Miyake, K ;
Kirschning, CJ ;
Gupta, D .
JOURNAL OF IMMUNOLOGY, 2001, 166 (03) :1938-1944
[6]   Human Toll-like receptor 2 mediates monocyte activation by Listeria monocytogenes, but not by group B streptococci or lipopolysaccharide [J].
Flo, TH ;
Halaas, O ;
Lien, E ;
Ryan, L ;
Teti, G ;
Golenbock, DT ;
Sundan, A ;
Espevik, T .
JOURNAL OF IMMUNOLOGY, 2000, 164 (04) :2064-2069
[7]   SOLUBLE CD14 PARTICIPATES IN THE RESPONSE OF CELLS TO LIPOPOLYSACCHARIDE [J].
FREY, EA ;
MILLER, DS ;
JAHR, TG ;
SUNDAN, A ;
BAZIL, V ;
ESPEVIK, T ;
FINLAY, BB ;
WRIGHT, SD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (06) :1665-1671
[8]   LIPOPOLYSACCHARIDE (LPS) SIGNAL-TRANSDUCTION AND CLEARANCE - DUAL ROLES FOR LPS BINDING-PROTEIN AND MEMBRANE CD14 [J].
GEGNER, JA ;
ULEVITCH, RJ ;
TOBIAS, PS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (10) :5320-5325
[9]  
Hailman E, 1996, J IMMUNOL, V156, P4384
[10]   Signaling by Toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages [J].
Hirschfeld, M ;
Weis, JJ ;
Toshchakov, V ;
Salkowski, CA ;
Cody, MJ ;
Ward, DC ;
Qureshi, N ;
Michalek, SM ;
Vogel, SN .
INFECTION AND IMMUNITY, 2001, 69 (03) :1477-1482